Portfolio

TOP
>
Portfolio
>
J-Pharma Co., Ltd.

J-Pharma Co., Ltd.

Drug development targeting amino acid transporter LAT1 (SLC7A5); development of drugs forbiliary tract cancer and pancreatic cancer is ongoing              

Providing new treatment options for many patients suffering from incurable diseases such as biliary tract cancer and pancreatic cancer

Joint research with leading universities in Japan, the University of Colorado (U.S.), the National Science Center in Nice (France), and Khon Kaen University(Thailand), etc.

topics

/

/

/

/

/

/

Overview of investee companies

  • Company name

    J-Pharma Co., Ltd.

  • Type of business

    Medical(medical devices, drug discovery)

  • Representatives

    Masuhiro Yoshitake

  • Establishing a company

    December 2005

  • Investment announcement date

    July 2021

  • Capitalist

    Takuma Tsuzuku

  • HP

    https://www.j-pharma.com/
  • Phasing

    Middle to Growth

Contents

Related news

back